Onset and progression of <i>de novo</i> donor‐specific anti‐human leukocyte antigen antibodies after <scp>BK</scp> polyomavirus and preemptive immunosuppression reduction

Abstract

Post-transplant BKPyV viremia and preemptive immunosuppression reduction is associated with high rates of dnDSA. When preemptively treating BKPyV viremia, dnDSA should be monitored to prevent allograft consequences.